Taiwan FDA registration 4e83a24ce9d6d451b57ebd9222b6a696
Rifu-angioconstrictin conversion/assay reagent
TW: 日富-血管收縮素轉換/檢驗試劑
Taiwan·Risk Class 2·FUJIREBIO INC., HACHIOJI FACILITY·Registered Dec 09, 2005 – Dec 09, 2025CancelledRegistration details
- Analysis ID
- 4e83a24ce9d6d451b57ebd9222b6a696
- Customs Code
- DHA00601537001
Company information
- Manufacturer
- FUJIREBIO INC., HACHIOJI FACILITY
- Manufacturer Country
- Japan
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Intended Use
- 檢測人血清中之血管收縮素轉換? [Angiotensin Converting Enzyme (ACE)].
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1090 Vasopressin-converting enzyme testing system
- Import Information
- import
Dates and status
- Registration Date
- Dec 09, 2005
- Expiry Date
- Dec 09, 2025
- Cancellation Date
- Oct 28, 2022
Cancellation information
- Status
- Logged out
- Reason
- 公司歇業
About this record
Access comprehensive regulatory information for Rifu-angioconstrictin conversion/assay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4e83a24ce9d6d451b57ebd9222b6a696 and manufactured by FUJIREBIO INC., HACHIOJI FACILITY. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices